Akers Biosciences (NASDAQ:AKER) Stock Price Passes Below 50 Day Moving Average of $0.46

Akers Biosciences Inc (NASDAQ:AKER) crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.46 and traded as low as $0.44. Akers Biosciences shares last traded at $0.44, with a volume of 1,200 shares trading hands.

The stock’s 50 day simple moving average is $0.46.

Akers Biosciences (NASDAQ:AKER) last released its quarterly earnings data on Monday, May 20th. The medical instruments supplier reported ($0.07) earnings per share (EPS) for the quarter. Akers Biosciences had a negative net margin of 501.62% and a negative return on equity of 135.24%. The company had revenue of $0.61 million during the quarter.

An institutional investor recently bought a new position in Akers Biosciences stock. Bank of New York Mellon Corp purchased a new stake in Akers Biosciences Inc (NASDAQ:AKER) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 34,274 shares of the medical instruments supplier’s stock, valued at approximately $39,000. Bank of New York Mellon Corp owned about 0.27% of Akers Biosciences as of its most recent SEC filing. Institutional investors own 8.43% of the company’s stock.

Akers Biosciences Company Profile (NASDAQ:AKER)

Akers Biosciences, Inc, together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. The company's marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness.

Featured Story: Options Trading – Understanding Strike Price

Receive News & Ratings for Akers Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akers Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.